STDCheck Review (2026): Panels, Pricing, Turnaround, and Privacy

STDCheck is the most-searched name in direct-to-consumer STD testing, and it earns the attention with an unusually focused pitch: order online, walk into a nearby lab, get results fast. This review lays out what the service publishes about itself — panels, prices, turnaround, privacy — alongside the trade-offs its own model implies. The usual frame applies throughout: screening is not diagnosis. A test can flag something worth acting on; what a result means for you, and what happens next, is a conversation for a licensed healthcare provider. For background on testing itself, the CDC's Getting Tested for STIs pages and MedlinePlus's STI test explainers are the primary public references.

What STDCheck is

STDCheck is a lab-visit service: you buy a test or panel online, receive a lab order (no doctor's appointment on your side), and visit one of what the company states are more than 4,500 testing centers nationwide for a quick professional collection. Nothing ships to your home. The company states results are typically available within 1–2 days of your visit, posted to a private online portal.

Two more published claims worth noting with attribution: STDCheck describes its tests as "FDA-approved/cleared" and states that its testing locations "meet and exceed" CLIA standards — CLIA being the federal lab-quality program administered by CMS with CDC involvement. Those are the service's claims about itself; the useful takeaway is that it operates inside the same federal lab-certification framework as clinical testing generally.

The 10-Test Panel, itemized

Panel names are marketing; contents are facts. Per STDCheck's own panel page, the flagship 10-Test Panel ($139 as published) covers:

Collection is a small blood draw plus a urine sample, in one visit. A 13-Test Panel ($259 as published) extends the list, and a low-cost Wellness Panel ($49) sits alongside for general markers. Individual tests are published from $24 (the hepatitis tests) up to $129 for HIV RNA early detection, which can also be added to a panel for a published $119.

Panel contents are also where a balanced review should slow down. Herpes antibody testing, for example, is included here but treated carefully in public guidance — the CDC's published screening recommendations do not recommend routine herpes blood screening for people without symptoms. That is not a knock on the service; it is a reminder that which tests are worth running is exactly the question a healthcare provider — not a checkout page, and not this review — should help you answer. MedlinePlus's herpes test page explains the test itself in plain language.

Timing, and what the turnaround claim covers

The stated 1–2 day clock starts at your lab visit — there is no shipping on either end, which is the structural speed advantage of the lab-visit model over mail-in kits. What no turnaround claim covers is the window period: every infection has an interval after exposure before any test can reliably detect it. STDCheck publishes window-period guidance per test (its site states its HIV 4th-gen test is "conclusive" at three weeks post-exposure — the company's claim), and the CDC's HIV testing pages cover the public guidance. Testing earlier than the window can produce false reassurance regardless of the service — timing questions belong with a clinician, especially after a known exposure. Our explainer on what turnaround times really mean goes deeper.

Pricing and payment

Published prices at the time of writing: individual tests $24–$129; 10-Test Panel $139; 13-Test Panel $259. Payment is cash-pay by design — the service states results are not reported to insurance and therefore do not enter your insurance record, a structural privacy property covered in our cash-pay and privacy guide. The flip side of cash-pay is honest too: if you have good coverage, clinician-ordered testing through insurance — or free and low-cost community options, which the CDC's testing pages point to — may cost you less out of pocket. See our full STD panel cost guide for the category-wide numbers.

One availability note: a few states — New York, New Jersey, and Rhode Island are the usual examples — regulate direct-to-consumer lab ordering differently than most. Confirm your state in the service's own checkout or FAQ rather than assuming.

Privacy practices, as published

The privacy stack STDCheck publishes: no kit in the mail (nothing to intercept), portal-only results, discreet billing, and the no-insurance-record structure above. As with every service, some limits are legal, not corporate: certain positive results are reportable to public-health authorities by law wherever you test. Our privacy comparison walks the whole category through these axes.

After a positive

STDCheck states that its medical team is available to discuss certain positive results and that its physicians can, where appropriate, prescribe treatment for some conditions. That is the service's published description of its own follow-up — the general rule still holds: a positive screen is the start of a clinical conversation, typically involving confirmation and care decisions with a provider who knows your situation.

Pros and cons

Pros: dedicated STD focus with itemized panels; large stated center network (4,500+); short stated turnaround (1–2 days, no mail time); professional collection; cash-pay with a published no-insurance-record practice; published per-test window-period guidance; consult-on-positive policy.

Cons: requires a lab visit — not an option if never-leave-home is the point (see the mail-in comparison); cash-pay only, so insurance holders may pay more than an in-network route; panel includes tests (like herpes serology) that public guidance treats as situational — worth a provider conversation before paying for them; STD-only menu, so broader blood work means a second service like Personalabs.

Verdict

Within the lab-visit lane, STDCheck is the cleanest execution of the focused model: the most panel per dollar at its published $139 flagship price, the shortest stated turnaround in the category, and privacy properties that come from the structure rather than promises. Compare it against mail-in kits if home collection matters (that comparison is here) and against the full field before deciding — and take the screening-vs-diagnosis line seriously: the service can run the test; what it means belongs with your provider.

---

This article is for informational purposes only. This is not medical advice — consult a healthcare provider about testing decisions and what results mean for you. Some links on this page are affiliate links; we may earn a commission at no extra cost to you, and it never changes a comparison. LabScored is an independent publisher, not a healthcare provider or laboratory.